by Immune Technology Corp. | Nov 7, 2019 | News
WHO released the recommended composition of influenza virus vaccines for use in the 2020 southern hemisphere influenza season. They are: an A/Brisbane/02/2018 (H1N1)pdm09-like virus; an A/South Australia/34/2019 (H3N2)-like virus; * a B/Washington/02/2019-like...
by Immune Technology Corp. | Jul 30, 2020 | News
IT-002-032p: Recombinant Spike Protein from Novel Coronavirus (SARS-CoV-2/Wuhan/2019), Trimeric The novel coronavirus pandemic, COVID-19, has catalyzed the development of vaccines and antiviral drugs across the biotech industry, both by pharmaceutical companies and...
by Immune Technology Corp. | Jul 30, 2020 | News
SARS-CoV-2 (2019-nCoV) and Related Products (SARS, MERS, Coronavirus HKU and etc. See link below): Antigens https://immune-tech.com/product-category/bacterial-and-viral-antigens/viral-antigens/coronoviruses-proteins/https://immune-tech.com/index.php?cPath=23_46...
